7ea5 Citations

Cryo-EM structure of SETD2/Set2 methyltransferase bound to a nucleosome containing oncohistone mutations.

OpenAccess logo Cell Discov 7 32 (2021)
Cited: 11 times
EuropePMC logo PMID: 33972509

Abstract

Substitution of lysine 36 with methionine in histone H3.3 (H3.3K36M) is an oncogenic mutation that inhibits SETD2-mediated histone H3K36 tri-methylation in tumors. To investigate how the oncohistone mutation affects the function of SETD2 at the nucleosome level, we determined the cryo-EM structure of human SETD2 associated with an H3.3K36M nucleosome and cofactor S-adenosylmethionine (SAM), and revealed that SETD2 is attached to the N-terminal region of histone H3 and the nucleosome DNA at superhelix location 1, accompanied with the partial unwrapping of nucleosome DNA to expose the SETD2-binding site. These structural features were also observed in the previous cryo-EM structure of the fungal Set2-nucleosome complex. By contrast with the stable association of SETD2 with the H3.3K36M nucleosome, the EM densities of SETD2 could not be observed on the wild-type nucleosome surface, suggesting that the association of SETD2 with wild-type nucleosome might be transient. The linker histone H1, which stabilizes the wrapping of nucleosome DNA at the entry/exit sites, exhibits an inhibitory effect on the activities of SETD2 and displays inversely correlated genome distributions with that of the H3K36me3 marks. Cryo-EM analysis of yeast H3K36 methyltransferase Set2 complexed with nucleosomes further revealed evolutionarily conserved structural features for nucleosome recognition in eukaryotes, and provides insights into the mechanism of activity regulation. These findings have advanced our understanding of the structural basis for the tumorigenesis mechanism of the H3.3K36M mutation and highlight the effect of nucleosome conformation on the regulation of histone modification.

Reviews - 7ea5 mentioned but not cited (1)



Reviews citing this publication (5)

  1. SETD2: from chromatin modifier to multipronged regulator of the genome and beyond. Molenaar TM, van Leeuwen F. Cell Mol Life Sci 79 346 (2022)
  2. Ready, SET, Go: Post-translational regulation of the histone lysine methylation network in budding yeast. Separovich RJ, Wilkins MR. J Biol Chem 297 100939 (2021)
  3. Exploring the Molecular Underpinnings of Cancer-Causing Oncohistone Mutants Using Yeast as a Model. Zhang X, Fawwal DV, Spangle JM, Corbett AH, Jones CY. J Fungi (Basel) 9 1187 (2023)
  4. Histone methyltransferase SETD2: An epigenetic driver in clear cell renal cell carcinoma. Yu M, Qian K, Wang G, Xiao Y, Zhu Y, Ju L. Front Oncol 13 1114461 (2023)
  5. Structural and functional specificity of H3K36 methylation. Lam UTF, Tan BKY, Poh JJX, Chen ES. Epigenetics Chromatin 15 17 (2022)

Articles citing this publication (5)

  1. SMYD5 catalyzes histone H3 lysine 36 trimethylation at promoters. Zhang Y, Fang Y, Tang Y, Han S, Jia J, Wan X, Chen J, Yuan Y, Zhao B, Fang D. Nat Commun 13 3190 (2022)
  2. Clinical and genetic features of luscan-lumish syndrome associated with a novel de novo variant of SETD2 gene: Case report and literature review. Zhang Y, Zhang H, Wu W, Wang D, Lv Y, Zhao D, Wang L, Liu Y, Zhang K. Front Genet 14 1081391 (2023)
  3. Computational Study of Methionine Methylation Process Catalyzed by SETD3. Zhao YY, Deng H, Rahman A, Xu XL, Qian P, Guo H. Interdiscip Sci 14 929-936 (2022)
  4. Mechanistic basis of the increased methylation activity of the SETD2 protein lysine methyltransferase towards a designed super-substrate peptide. Schnee P, Choudalakis M, Weirich S, Khella MS, Carvalho H, Pleiss J, Jeltsch A. Commun Chem 5 139 (2022)
  5. Nucleosomes and their complexes in the cryoEM era: Trends and limitations. Armeev GA, Gribkova AK, Shaytan AK. Front Mol Biosci 9 1070489 (2022)